INFU: InfuSystem Holdings, Inc. Company Total Sales

InfuSystem Holdings (INFU) trading revenue dynamics confirm sustainable pricing power driven by clinic dependency on the service. The 0.14 metric reflects current trends resulting from the creation of a closed medical ecosystem with a full control cycle. Revenues are based on infusion pump rentals and logistics for oncology centers, ensuring a stable cash flow from service delivery.

InfuSystem Inc (INFU) - Company Sales from 07/04/2022 to 11/14/2026

Comprehensive metric breakdowns and analytics for InfuSystem (INFU)

- market value and analyst target forecast:

Market Chart InfuSystem Holdings, Inc.|INFU - Consensus Target

- market capitalization information:

Market Value InfuSystem Inc|INFU - Total Company Value

- book capitalization indicators:

Accounting Value of a Share InfuSystem Holdings|INFU - Company Net Assets|Market Capitalization to Book Value Ratio infusystem.com|INFU - Aggregate Company Assets

- company liabilities and liquidity data:

- earnings and valuation multiples indicators:

INFU - Net Profit|Company Profit Forecast InfuSystem Holdings|INFU - Price to Earnings Ratio|Price to Future Earnings Ratio InfuSystem Holdings|INFU - PEG Multiple|Company Value to Operating Income Before Depreciation Ratio INFU|INFU - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) InfuSystem Holdings|INFU - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months infusystem.com|INFU - Net earnings per share growth this year|Expected net earnings per share growth next year InfuSystem Holdings

- issuer revenue and sales details:

INFU - Company Revenue|Company Future Sales InfuSystem Holdings, Inc.|INFU - Market Cap to Revenue|Price to Expected Revenue Ratio InfuSystem

Comprehensive company analysis:InfuSystem Inc INFU

Signature product of InfuSystem Holdings, Inc.

Stable revenue growth drives the long-term investment attractiveness of InfuSystem Holdings (INFU) through fundamental multiples. By analyzing the company's annual sales volume on GURU.Markets, an investor can assess the actual cash flow velocity, stripped of market noise. This metric identifies deviations from normal distribution, signaling demand risks. In this instance, the stability of the indicator is supported by a stringent FDA regulatory barrier. Integration into hospital IT systems precludes startup expansion, guaranteeing predictability of execution.

Competing companies